By Stephen C. Taylor, PhD
BIOCONTRACT SERVICES:
A Supplement to BPJ Volume 3, Issue 3 (May/June 2004)
How do we ensure that the next generation of biotech medicines can be brought to market in a timely way, that they continue to be safe and effective and — of growing importance — are affordable by healthcare funding agencies, and profitable to the companies developing them?…
Citation: Taylor SC. Beyond the Stainless Steel — The Real Capacity Crunch… BioProcess J, 2004; 3(3, Suppl. 2): S21-27. https://doi.org/10.12665/BCS2.Taylor
Posted online July 19, 2026